INTRODUCTION
The infection caused by hepatitis E virus (HEV) is a significant public health problem in many parts of the world. 1, 2 This RNA virus circulates worldwide with at least two epidemiological profiles that allow to distinguish highly endemic regions from low endemic regions. 3, 4 The data reported in the last years have revealed the complex picture of the epidemiology of HEV infection in Latin America 5 In Argentina, locally acquired sporadic cases showing self-limited infection or acute liver failure in adults and children have been reported. [6] [7] [8] [9] [10] Swine genotype 3 HEV related to human variants has also been characterized. 11 Studies showing prevalence of anti-HEV in different groups were carried out in the 1990s. 12, 13 New serological assays have proven a better performance. 14, 15 We are presenting our latest findings from 2011 to 2013.
MATERIAL AND METHODS

Prevalence of human anti-HEV antibodies
In 2012, we have studied the prevalence of anti-HEV antibodies in 202 adult serum samples by means of two commercial kits. One hundred twentythree serum samples were taken from adults interested in being screened for hepatitis B virus (HBV) and hepatitis C virus (HCV). These people were first interviewed and asked to answer a brief survey with demographic data and parenteral risk factors as one of the activities offered for information and awareness on the World Hepatitis Day, on 28th 21 July 2012, in Buenos Aires city.
One commercial enzyme immunoassay (EIA) (HEV IgG, DiaPro Diagnostic Bioprobes, Milan, Italy) was used to detect anti-HEV IgG antibodies in 95 out of those 123 samples. A second commercial EIA kit (Wantai HEV IgG, Beijing, China) was used to detect anti-HEV IgG antibodies in the remaining 28 serum samples 1 and additional 79 serum samples. These came from anti-HIV-positive patients and blood donors referred to our laboratory from different Argentinian cities. Furthermore there were healthy healthcare workers working in a Buenos Aires city center who were checked for their immunity against HBV.
The information is summarized in Table 1 .
Diagnosis of acute HEV infection
We studied serum samples from 143 patients (56% males) with acute non-A-C hepatitis, referred from hospitals of Buenos Aires and other Argentine provinces, obtained between 2011 and 2013. The median age of the patients was 45 years, ranging from 18 to 74 years old. Fecal samples were also available for 27 of them.
Serological diagnosis was carried out detecting total anti-HEV (IgM+IgG) antibodies (HEV Ab, DiaPro) or anti-HEV IgM antibodies (Wantai HEV IgM and HEV IgM, DiaPro EIA kits) upon availability. No commercial kit was available in the market in Argentina until 2013.
All serum and fecal samples were studied on arrival for HEV RNA by RT-nested PCR, using different sets of degenerated primers directed to the ORF1, ORF2 and ORF2/3 regions. 6, 16, 17 We detected the ORF2/3 and ORF2 regions simultaneously as they are the most sensitive in our hands. The ORF1 fragment was amplified for further investigation in samples with positive results for the other two amplified regions. In PCR-positive cases, purified PCR products were sequenced, characterized and analyzed as previously described. 7, 8, 11 Swine fecal samples Fecal samples were obtained by rectal swab from 73 out of 720 1-to 3-month-old pigs from two commercial herds from Mendoza province (west-center of Argentina) in 2012.
Additional 21 fecal samples from 1-to 3-month-old pigs from a commercial herd from Santa Fe province (north-center of Argentina) were also 1 studied in 2011. HEV RNA was processed in the same way as for the human samples previously described.
RESULTS
Prevalence of human anti-HEV antibodies
Nine out of the ninety-five samples studied with the DiaPro IgG assay were positive. The seroprevalence for this group of people, who were voluntarily screened for HBV and HCV, was 9.5%.
The overall prevalence of anti-HEV antibodies in sera detected by the Wantai IgG assay was 20.6%. Twenty-two out of 107 samples were reactive. However, when we considered the anti-HEV prevalence according to each subgroup, the proportions of reactive samples varied.
Results and demographic data from reactive samples are summarized in table 1.
The global distribution of anti-HEV IgG-positive samples according to the age is shown in figure 1 .
Diagnosis of acute HEV infection
From January 2011 to December 2013 we diagnosed nine acute infections with HEV.
Results are summarized in table 2. In July 2011, two males, 29 and 54 years old, were total anti-HEV-positive but had undetectable HEV RNA.
The length of the ORF2 sequences varied between 98 and 148 nucleotides, while those of ORF1 had 235 and 285 nucleotides. The genotype and subtype were assigned one by one by means of a careful phylogenetic analysis of the best sequences for each case, taking into account the highest hits in GenBank. ORF2/3a Ate porcine products. Phylogenetic trees were made with the necessary length permitting the inclusion of the largest number of cases possible (Figure 2 ). Patient 1's sequences clustered with a local 3a variant from 1 2010 but the precedent of traveling to the USA and the Caribbean did not rule out an imported case.
The sequences from the four patients characterized between October and December 2013 had a high homology in the ORF 2 (100%) and ORF 1 (98%) fragments of varied length. They were closely related to the one characterized in Buenos Aires in 2010. 8 Two of the patients became infected in Mendoza (center-west of Argentina) and Salta (NorthWest of Argentina).
Other patient had the precedent of travel to Jujuy (north-west of Argentina). A temporal rather than geographical association of the variants has been previously reported. 8, 17 HEV RNA in swine fecal samples Fifty nine out of the 73 (81%) swine fecal samples from Mendoza were HEV RNA positive (Table 3) . Three PCR products were sequenced from each herd. The six sequences were identical in the ORF2 fragment (Figure 2A) .
Another six new swine variants were obtained in Santa Fe from the six HEV RNA positive samples (Figure 2A ).
DISCUSSION
This study shows higher anti-HEV prevalence with the two kits assayed than that with the Abbott commercial kit reported in Argentina in the 1990's. The small number of samples we studied in the different subgroups is a limitation and larger studies are needed to confirm these results. With the only assay available at that time, it was found that 1.81% of a group of blood donors and 3.11% of a group of patients from Buenos Aires who had to undergo surgery had anti-HEV antibodies. 12 The mean age of both groups was significantly different, 34.2 vs. 46.7 years old. A multicenter study in HIV positive patients showed that 6.6 % of them had anti-HEV antibodies. 13 The mean age was 29 years old.
Higher anti-HEV antibodies prevalence in blood donors and healthcare 1 workers with the Wantai assay had been previously reported. 14, 15, 18 Higher prevalences in HIV-positive patients have been found in many studies. Yet, it has been suggested that dietary patterns, certain social habits, sanitation factors, geographical situation and the EIA tests used for the detection of anti-HEV IgG antibodies may play a significant role in explaining such differences. 19, 20 A recent study has shown that both the Diapro and Wantai IgM assays diagnose HEV genotype 3 acute infection adequately in a clinical setting. 21 Another study has shown that both assays perform well in immune-compromised patients. 22 Regarding immune-suppressed patients, it is essential to determine HEV-RNA because antibodies may appear later or even be absent. 1 Although it has been suggested that a high proportion of patients infected with genotype 3 are asymptomatic, we consider that HEV infection in Argentina is underestimated.
No routine screening is currently done in Argentina for HEV in patients with unexplained acute or chronic liver disease. The optimal diagnosis is too expensive to be widely tested in certain patients that require not only serological markers but also HEV RNA detection in serum and fecal samples, as shown in the cases reported in this work.
Individual patterns of HEV RNA in serial serum and fecal samples from patients from highly endemic regions have been demonstrated. 23 It has been reported that symptomatic HEV infection is much more common in middle aged and elderly patients 1, 2 and that men outnumbered women by at least 3 to 1. 4 This is the pattern found in our cases reported here. Genotype 3 is still the only one characterized in autochthonous cases in Argentina. This genotype has also been responsible for a wide range of severe disease. We consider that HEV has been poorly studied in the wide spectrum of the associated conditions reported. 2, 4, 24 
